tiprankstipranks
TipRanksTop Financial ExpertsInsidersJohn Orwin

John Orwin Insider Profile

4 Followers
John Orwin, Director at First Tracks Biotherapeutics Inc, holds 16.70K shares in First Tracks Biotherapeutics Inc (Ticker: TRAX), holds 16.70K shares in AnaptysBio (Ticker: ANAB), holds 39.38K shares in Travere Therapeutics (Ticker: TVTX).
See the Hottest Stocks Based on Insider Trading >
tipranks
John Orwin

John Orwin
First Tracks Biotherapeutics Inc (TRAX)
Director

Ranked #11,957 out of 108,921 Corporate Insiders

Profitable Transactions

75%
3 out of 4 Profitable Transactions

Average Return

+51.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$4M
60.29%
22.24%
15.84%
1.62%
0.00% Others
A breakdown of John Orwin's holdings
See the Top Stocks by Insiders

Insider Roles

Travere Therapeutics
(TVTX)
Director
AnaptysBio
(ANAB)
Director
First Tracks Biotherapeutics Inc
(TRAX)
Director
Array Technologies
(ARRY)
Director
+1 other positions
Roles that John Orwin holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Seagen
(SGEN)
Rating:Informative Buy
Date:Feb 17, 2016 - Feb 17, 2017
Return:+107.20%
The most profitable trade made by John Orwin
See the Latest Stocks Traded by Insiders

John Orwin's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
TRAX
First Tracks Biotherapeutics Inc
Jun 17, 2026
Director
Uninformative Buy
107.82K
$675.48K
RLYP
Relypsa Inc
Aug 17, 2016
―
Uninformative Sell
127.37K
$1.74M
TVTX
Travere Therapeutics
May 21, 2026
Director
Uninformative Buy
―
$2.57M
BCEL
Atreca
Apr 17, 2024
―
Informative Buy
0.01
$6.98K
ANAB
AnaptysBio
Jun 17, 2026
Director
Uninformative Buy
358.85K
$948.28K
CRGX
CARGO Therapeutics, Inc.
―
―
―
―
ARRY
Array Technologies
Oct 27, 2017
Director
Uninformative Buy
52.35K
$69.00K
SGEN
Seagen
Dec 15, 2023
―
Uninformative Sell
6.64M
$0.00
~ARRY
Array Biopharma
Jul 30, 2019
―
Uninformative Sell
720.00K
$0.00
AFFY
Affymax
Jun 28, 2013
Director
Uninformative Sell
16.66K
―
NGSX
Neurogesx
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see John Orwin's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

John Orwin insider profile FAQ

What is the percentage of profitable transactions made by John Orwin?
The percentage of profitable transactions made by John Orwin is 75%.
    What is the average return per transaction made by John Orwin?
    The average return per transaction made by John Orwin is 51.90%.
      What stocks does John Orwin hold?
      John Orwin holds: TRAX, RLYP, TVTX, BCEL, ANAB, CRGX, ARRY, SGEN, ~ARRY, AFFY, NGSX stocks.
        What was John Orwin’s latest transaction?
        John Orwin latest transaction was an Uninformative Buy of $107.82K.
          What was John Orwin's most profitable transaction?
          John Orwin’s most profitable transaction was an Informative Buy of SGEN stock on February 17, 2016. The return on the trade was 107.20%.
            What is John Orwin's role in First Tracks Biotherapeutics Inc?
            John Orwin's role in First Tracks Biotherapeutics Inc is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.